Showing results (21-30 of 2,470) with videos related to
Sort By:
Pageof 247
Frontiers in Immunology|August 24, 2019
IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis PatientsYuling Shi, Zeyu Chen, Zihan Zhao, et al.Frontiers in Immunology|June 13, 2022
Based on Gene Expression Analysis: Low-Density Neutrophil Expression Is a Characteristic of the Fast Responders Treated With Guselkumab for PsoriasisJiajing Lu, Yu Wang, Ying Li, et al.Oncotargets and Therapy|October 6, 2018
Scalp metastases as first presentation of pulmonary adenocarcinomas: a case reportQian Yu, Smriti Subedi, Yunlei Tong, et al.Scientific Reports|November 16, 2017
Yes-Associated Protein (YAP) Promotes Tumorigenesis in Melanoma Cells Through Stimulation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1)Huizi Xiong, Qian Yu, Yu Gong, et al.International Immunopharmacology|June 3, 2019
Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasisQian Yu, Yunlei Tong, Lian Cui, et al.Psoriasis (Auckland, N.Z.)|June 1, 2026
Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in PsoriasisYingyuan Yu, Bingjie Li, Yu Wang, et al.Journal of Cosmetic Dermatology|January 12, 2022
Efficacy and safety of two hyaluronic acid fillers with different injection depths for the correction of moderate-to-severe nasolabial folds: A 52-week, prospective, randomized, double-blinded study in a Chinese populationYifan Hu, Zhiyu Liu, Yao Wang, et al.Biochemical and Biophysical Research Communications|June 12, 2019
Ginsenoside compound K ameliorates imiquimod-induced psoriasis-like dermatitis through inhibiting REG3A/RegIIIγ expression in keratinocytesHuayu Fan, Yao Wang, Xilin Zhang, et al.Frontiers in Pharmacology|May 3, 2021
Xiao-Yin-Fang Therapy Alleviates Psoriasis-like Skin Inflammation Through Suppressing γδT17 Cell PolarizationXilin Zhang, Xiaorui Li, Youdong Chen, et al.European Journal of Dermatology : EJD|September 6, 2022
Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective studyHui Qin, Na Liu, Yifan Hu, et al.Pageof 247